Brief: Theraclion FY Operating Loss Widens To EUR 4.5 Mln

Theraclion SA

31/03/2022 18:09

March 31 (Reuters) - Theraclion SA  ALTHER.PA :
    * 2021 RESULTS IN LINE WITH THERACLION'S DEVELOPMENT
STRATEGY FOR
2022
    * CASH POSITION IS EUR 2.5 MILLION AT DECEMBER 31, 2021
    * END-DEC NET LOSS EUR 3.8 MILLION VERSUS LOSS OF EUR 3.9
MILLION
YEAR AGO
    * ON MARCH 1ST, 2022, CO COMPLETED CAPITAL INCREASE OF EUR
6.5
MILLION, INCLUDING ISSUE PREMIUM, WHICH SHOULD ALLOW THERACLION
TO MEET ITS CASH FLOW NEEDS FOR NEXT 12 MONTHS
    * FINANCIAL RESULT IS A LOSS OF 136 KEUR FOR YEAR
    * TURNOVER OF EUR 1,481K IN 2021, AN INCREASE OF 99%
COMPARED TO
2020
    * CASH NEEDS ARE COVERED FOR NEXT 12 MONTHS
    * COMPANY MAINTAINS ITS SUSTAINED INVESTMENT POLICY WITH
TOTAL
RESEARCH AND DEVELOPMENT COSTS STANDING AT EUR 3.8M (COMPARED TO
EUR 2.1M IN 2020)
    * RESEARCH TAX CREDIT AMOUNTED TO 883 KEUR AT END OF
DECEMBER 2021
COMPARED TO 722 KEUR YEAR AGO
    * FY OPERATING LOSS EUR 4.5 MILLION VERSUS LOSS EUR 4.3
MILLION
YEAR AGO

Source text for Eikon:  urn:newsml:reuters.com:*:nBw2pxdPQa
Further company coverage:  ALTHER.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))